Stay updated on RTA 408 Capsules in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page.

Latest updates to the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe ClinicalTrials.gov record for the omaveloxolone study in people with Friedreich’s ataxia is displayed, with study details, results measures, participant criteria, locations, and data-sharing and study documents.SummaryDifference81%

- Check21 days agoChange DetectedThe displayed site revision changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedA site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check35 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check42 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check63 days agoChange DetectedThe study record page now shows a 403 Forbidden error, blocking access to the trial details and related links. The previous content and documents listed on the page are no longer accessible.SummaryDifference22%

Stay in the know with updates to RTA 408 Capsules in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTA 408 Capsules in Friedreich's Ataxia Clinical Trial page.